Sign up to our newsletter Subscribe
Bridging the Gap: Pathways for Regulatory and Health Technology Assessment of Histology Independent Therapies

New medicines lead to improved patient outcomes and societal benefits, but R&D is a long and costly process. Ongoing health economics research aims to find the right balance between incentivising manufacturers to innovate and ensuring affordable access for health systems.